相关实验视频
Updated: Jul 5, 2025

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.4K
葡萄糖氨基糖:参与了败血症微血管凝血的参与者
Nanxi Li1, Ruolin Hao1, Peng Ren2
1Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China.
Thrombosis and haemostasis
|January 19, 2024
概括
败血症涉及过度的炎症和凝血,导致微血管血栓症和器官功能障碍. 葡萄糖氨基甘氨酸在败血症引起的凝血中起着关键作用,可能有助于预测患者的结果.
科学领域:
- * 传染病的病理生理学.
- * 血液学和血栓形成
- * 内皮细胞生物学和血管功能
背景情况:
- * 败血症是一种全球性健康威胁,其特点是对感染的全身炎症反应.
- *严重的败血症涉及过度炎症和高凝血,导致高死亡率.
- *微血管血栓和随后的器官功能障碍是败血症患者的主要死亡原因.
研究的目的:
- * 审查内皮损伤,炎症和血症在败血症中的相互作用.
- *阐明糖氨基氨基甘油在凝血中的作用及其与血液细胞的相互作用.
- *讨论目前在败血症中检测微血管功能障碍的检测方法.
主要方法:
- * 关于败血症病理生理学的现有研究的文献综述.
- * 分析糖氨基氨基酸在凝血路径中的作用.
- * 检查在败血症中微血管疾病的诊断方法.
主要成果:
- * 败血症引起的内皮损伤释放糖氨基,促进微血管功能障碍.
- * 葡萄糖氨基糖与血小板和炎症细胞相互作用,导致血栓形成.
- *确定了潜在的信号通路,涉及葡萄糖氨基酸甘油在与败血症相关的凝血中.
结论:
- * 葡萄糖氨基甘油是血症中微血管血栓形成的关键媒介.
- *监测葡萄糖氨基水平可以帮助预测败血症的进展和结果.
- * 准糖氨基甘氨酸通路可能为败血症提供新的治疗策略.
相关概念视频
Glycosaminoglycans
4.8K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
4.8K
Introduction to Hemostasis
7.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.8K
Coagulation
6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K
Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701

